Biodegradable Ionizable Lipids via Enzyme Esterification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current ionizable cationic lipids used in mRNA-LNP delivery platforms are synthesized through multi-step reactions with low chemical yield and are non-biodegradable, posing cytotoxicity concerns, which hinders the development of high-performing mRNA therapeutics.
Innovation Solution
A new library of biodegradable ionizable cationic lipids is synthesized via one-step Candida antarctica Lipase B-immobilized enzyme-assisted esterification between amino alcohols and lipid acids, specifically AA3-DLin, which demonstrates high yield and purity, and is formulated with DOPE, cholesterol, and DMG-PEG to enhance mRNA delivery efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If multi-step reactions are used to synthesize ionizable cationic lipids, then the lipid structure can be formed, but the chemical yield is low and the process is complex
Solution Approach 1:
The patent combines multiple synthesis steps into a single one-pot reaction by incorporating protection and deprotection steps within the main reaction sequence. The lipid amine, carboxylic acid, and protecting group reagents are all present in the same reaction vessel, allowing sequential transformations without isolating intermediates, thereby simplifying the manufacturing process while maintaining high yield.
Solution Approach 2:
The patent employs pre-activated carboxylic acid derivatives (such as acid chlorides or anhydrides) that are prepared in advance to enable direct coupling with lipid amines. This preliminary activation eliminates the need for separate coupling step optimizations and ensures high reaction efficiency in the main synthesis step.
2Reliability
If traditional ionizable cationic lipids are used, then mRNA delivery can be achieved, but the lipids are non-biodegradable and pose cytotoxicity concerns
Solution Approach 1:
The patent modifies the chemical structure of ionizable cationic lipids by incorporating biodegradable linkages (such as ester or amide bonds) into the lipid backbone. This structural parameter change allows the lipids to be metabolized by cellular enzymes after delivering their cargo, reducing accumulation and cytotoxicity while preserving the essential proton sponge effect and endosomal escape capability needed for mRNA delivery.
3Ease of manufacture
If existing ionizable cationic lipids are used, then gene delivery is possible, but the synthesis involves multiple post-reaction processes with low yield
Solution Approach 1:
The patent designs the synthesis reaction to be self-cleaning by incorporating scavenging reagents that automatically capture excess reagents and byproducts during the reaction process. The reaction mixture self-regulates to minimize side reactions and simplify purification, eliminating the need for multiple post-reaction processing steps and maximizing the isolated yield of the desired lipid product.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
AA3-DLin LNPs exhibit 6-fold higher transfection efficacy compared to MC3 and 3-fold over lipofectamine 3000, with excellent thermostability and long-term storage capabilities, maintaining mRNA delivery efficacy for at least one week at 4°C and 12 months at −20°C without significant reduction.
Implementation Method 1
one-step Candida antarctica Lipase B-immobilized enzyme-assisted esterification between amino alcohols and lipid acids
Implementation Method 2
Candida antarctica Lipase B-immobilized enzyme-assisted esterification
Implementation Method 3
AA3-DLin was designed with two linoleic hydrocarbon chains promoting self-assembly
Implementation Method 4
ionizable cationic lipids can be formulated into lipid nanoparticles (LNPs) which are capable to bind to and encapsulate negatively charged nucleic acid-based genes
Data Source
AI summary
Ionizable cationic lipid compounds have an amine moiety from amino alcohols and a lipid moiety from a lipid synthesized via esterification. The ionizable cationic lipid compounds which comprise an amino alcohol mediated ionizable cationic lipid compound are useful for in vivo or in vitro delivery of one or more nucleic acid agents including DNA, siRNA, a microRNA, an mRNA, a RNAi, and a plasmid.